AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $24,180,000 | -45.2% | 484,759 | -25.1% | 0.33% | -44.4% |
Q1 2019 | $44,125,000 | +51.8% | 647,360 | +2.7% | 0.59% | +26.6% |
Q4 2018 | $29,067,000 | -41.6% | 630,379 | -2.4% | 0.46% | -31.1% |
Q3 2018 | $49,813,000 | -8.5% | 645,912 | -0.0% | 0.67% | -13.3% |
Q2 2018 | $54,413,000 | +0.6% | 646,009 | -2.3% | 0.78% | +1.7% |
Q1 2018 | $54,078,000 | +42.7% | 661,262 | -0.3% | 0.76% | +41.9% |
Q4 2017 | $37,909,000 | -22.2% | 663,089 | -9.1% | 0.54% | -36.6% |
Q3 2017 | $48,708,000 | +21.2% | 729,714 | -6.5% | 0.85% | +14.9% |
Q2 2017 | $40,172,000 | -26.4% | 780,800 | -16.5% | 0.74% | +80.6% |
Q1 2017 | $54,597,000 | +60.3% | 934,879 | +14.5% | 0.41% | +52.8% |
Q4 2016 | $34,060,000 | +0.7% | 816,200 | +27.5% | 0.27% | +4.7% |
Q3 2016 | $33,815,000 | +20.8% | 640,200 | -4.2% | 0.26% | +18.6% |
Q2 2016 | $27,990,000 | +62.6% | 668,100 | +57.6% | 0.22% | +62.9% |
Q1 2016 | $17,211,000 | -39.0% | 423,922 | -2.4% | 0.13% | -39.7% |
Q4 2015 | $28,197,000 | -3.7% | 434,341 | +4.7% | 0.22% | -7.6% |
Q3 2015 | $29,280,000 | -63.7% | 414,790 | -42.8% | 0.24% | -59.3% |
Q2 2015 | $80,663,000 | +12.7% | 725,780 | -4.4% | 0.58% | +9.6% |
Q1 2015 | $71,598,000 | -5.3% | 759,256 | +12.5% | 0.53% | +1.3% |
Q4 2014 | $75,615,000 | – | 674,890 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |